These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30382085)

  • 21. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles.
    Yallapu MM; Chauhan N; Othman SF; Khalilzad-Sharghi V; Ebeling MC; Khan S; Jaggi M; Chauhan SC
    Biomaterials; 2015 Apr; 46():1-12. PubMed ID: 25678111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
    Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
    ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
    Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
    Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface roughness influences the protein corona formation of glycosylated nanoparticles and alter their cellular uptake.
    Piloni A; Wong CK; Chen F; Lord M; Walther A; Stenzel MH
    Nanoscale; 2019 Dec; 11(48):23259-23267. PubMed ID: 31782458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link.
    Rezaei G; Daghighi SM; Raoufi M; Esfandyari-Manesh M; Rahimifard M; Mobarakeh VI; Kamalzare S; Ghahremani MH; Atyabi F; Abdollahi M; Rezaee F; Dinarvand R
    J Colloid Interface Sci; 2019 Nov; 556():476-491. PubMed ID: 31473538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy.
    Zhang Z; Wang C; Zha Y; Hu W; Gao Z; Zang Y; Chen J; Zhang J; Dong L
    ACS Nano; 2015 Mar; 9(3):2405-19. PubMed ID: 25587629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction.
    Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S
    Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Retargeting of Poly(beta aminoester) (OM-PBAE) Nanoparticles is Influenced by Protein Corona.
    Fornaguera C; Guerra-Rebollo M; Lázaro MÁ; Cascante A; Rubio N; Blanco J; Borrós S
    Adv Healthc Mater; 2019 Oct; 8(19):e1900849. PubMed ID: 31478348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars.
    D'Hollander A; Jans H; Velde GV; Verstraete C; Massa S; Devoogdt N; Stakenborg T; Muyldermans S; Lagae L; Himmelreich U
    Biomaterials; 2017 Apr; 123():15-23. PubMed ID: 28152380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles.
    Nguyen VH; Meghani NM; Amin HH; Tran TTD; Tran PHL; Park C; Lee BJ
    Colloids Surf B Biointerfaces; 2018 Oct; 170():179-186. PubMed ID: 29906703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
    Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
    Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery.
    Kim W; Ly NK; He Y; Li Y; Yuan Z; Yeo Y
    Adv Drug Deliv Rev; 2023 Jan; 192():114635. PubMed ID: 36503885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein corona in drug delivery for multimodal cancer therapy in vivo.
    Yeo ELL; Thong PSP; Soo KC; Kah JCY
    Nanoscale; 2018 Feb; 10(5):2461-2472. PubMed ID: 29336463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona.
    Sakulkhu U; Mahmoudi M; Maurizi L; Coullerez G; Hofmann-Amtenbrink M; Vries M; Motazacker M; Rezaee F; Hofmann H
    Biomater Sci; 2015 Feb; 3(2):265-78. PubMed ID: 26218117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes.
    Aoyama M; Hata K; Higashisaka K; Nagano K; Yoshioka Y; Tsutsumi Y
    Biochem Biophys Res Commun; 2016 Nov; 480(4):690-695. PubMed ID: 27983983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles: Implications for Tissue Binding and Tumor Penetration.
    Wadajkar AS; Dancy JG; Carney CP; Hampton BS; Ames HM; Winkles JA; Woodworth GF; Kim AJ
    Nanomedicine; 2019 Aug; 20():102024. PubMed ID: 31176045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: A too simplistic explanation that does not take into account the nanoparticle protein corona.
    Forest V; Pourchez J
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):889-896. PubMed ID: 27770966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nano-bio interfacial protein corona on silica nanoparticle.
    Zhang H; Peng J; Li X; Liu S; Hu Z; Xu G; Wu R
    Colloids Surf B Biointerfaces; 2018 Jul; 167():220-228. PubMed ID: 29656205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.